Brief Title
3 Year Recurrence Free Survival in Ultra-low-risk Endometrial Cancer
Official Title
Three-year Recurrence Free Survival in Patients With Ultra-low-risk Endometrial Cancer Who do Not Undergo Lymph Node dissEction
Brief Summary
To verify the safety of omission of lymph node dissection in ultra-low-risk endometrial cancer (KGOG criteria), we examine the survival of women with ultra-low-risk endometrial cancer who do not undergo lymph node dissection
Study Type
Observational
Primary Outcome
3 year recurrence free survival
Secondary Outcome
5 year recurrence free survival
Condition
Endometrial Cancer
Intervention
no lymph node dissection
Study Arms / Comparison Groups
Experimental
Description: women who do not undergo lymph node dissection
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
153
Start Date
April 2020
Completion Date
March 2027
Primary Completion Date
March 2025
Eligibility Criteria
Inclusion Criteria: - endometrioid type - anticipated surgery omitting lymph node dissection for endometrial cancer - pelvis MRI, CA125 - satisfying KGOG criteria - no distant metastasis - age 19 or more Exclusion Criteria: - other cancer within 5 yr - previous hysterectomy - previous therapy for endometrial cancer
Gender
Female
Ages
19 Years - N/A
Contacts
, 82 31 787 7262, [email protected]
Administrative Informations
NCT ID
NCT04227249
Organization ID
KGOG 3021
Responsible Party
Sponsor
Study Sponsor
Seoul National University Hospital
Study Sponsor
, ,
Verification Date
January 2020